Laura Joszt, MA

Laura Joszt headshot

Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including Population Health, Equity & Outcomes; Evidence-Based Oncology™; and The Center for Biosimilars®. She has been working on AJMC since 2014 and has been with AJMC’s parent company, MJH Life Sciences®, since 2011.

She has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.

Articles by Laura Joszt, MA

Trends in healthcare are driven by innovation, which is largely being driven by specialty innovation, Douglas M. Long, MBA, vice president of industry relations at IMS Health, said during the headline session "Marketplace Trends" at the Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo.

The Workgroup for Electronic Data Interchange sent a letter to HHS Secretary Sylvia M. Burwell on March 31 explaining that the 1-year delay for implementation of the International Classification of Diseases, Tenth Revision may have done more harm than good.

Implementing a value-based drug formulary that uses cost-effectiveness analyses after safety and efficacy decreased pharmacy costs by 3% in the first year, according to a study published in the Journal of Managed Care & Specialty Pharmacy.

Although the Supreme Court's decision on King v. Burwell could remove subsidies from the federal marketplace, Americans prefer HealthCare.gov over the state-run exchanges, according to poll results from right-wing advocacy group Foundation for Government Accountability.

Big data, interoperability, and patient engagement were the topics of discussion during one of the opening keynote sessions at the World Health Care Congress held March 22-25 in Washington, DC.



Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo